Novogene Statistics

Total Valuation

Novogene has a market cap or net worth of CNY 5.58 billion. The enterprise value is 4.15 billion.

Market Cap	5.58B
Enterprise Value	4.15B

Important Dates

The last earnings date was Tuesday, April 15, 2025.

Earnings Date	Apr 15, 2025
Ex-Dividend Date	May 31, 2024

Share Statistics

Novogene has 405.06 million shares outstanding. The number of shares has increased by 2.40% in one year.

Current Share Class	n/a
Shares Outstanding	405.06M
Shares Change (YoY)	+2.40%
Shares Change (QoQ)	+1.41%
Owned by Insiders (%)	53.05%
Owned by Institutions (%)	13.24%
Float	128.58M

Valuation Ratios

The trailing PE ratio is 28.35 and the forward PE ratio is 24.78.

PE Ratio	28.35
Forward PE	24.78
PS Ratio	2.60
PB Ratio	2.18
P/TBV Ratio	2.24
P/FCF Ratio	27.97
P/OCF Ratio	16.10
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.05, with an EV/FCF ratio of 20.81.

EV / Earnings	20.42
EV / Sales	1.94
EV / EBITDA	11.05
EV / EBIT	17.96
EV / FCF	20.81

Financial Position

The company has a current ratio of 2.49, with a Debt / Equity ratio of 0.02.

Current Ratio	2.49
Quick Ratio	2.09
Debt / Equity	0.02
Debt / EBITDA	0.13
Debt / FCF	0.25
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 8.43% and return on invested capital (ROIC) is 5.67%.

Return on Equity (ROE)	8.43%
Return on Assets (ROA)	4.07%
Return on Invested Capital (ROIC)	5.67%
Return on Capital Employed (ROCE)	8.92%
Revenue Per Employee	1.00M
Profits Per Employee	94,845
Employee Count	2,144
Asset Turnover	0.60
Inventory Turnover	5.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.92% in the last 52 weeks. The beta is 0.82, so Novogene's price volatility has been lower than the market average.

Beta (5Y)	0.82
52-Week Price Change	+1.92%
50-Day Moving Average	16.02
200-Day Moving Average	12.90
Relative Strength Index (RSI)	42.13
Average Volume (20 Days)	5,401,336

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novogene had revenue of CNY 2.14 billion and earned 203.35 million in profits. Earnings per share was 0.49.

Revenue	2.14B
Gross Profit	931.85M
Operating Income	231.19M
Pretax Income	230.95M
Net Income	203.35M
EBITDA	374.20M
EBIT	231.19M
Earnings Per Share (EPS)	0.49

Full Income Statement

Balance Sheet

The company has 1.51 billion in cash and 50.24 million in debt, giving a net cash position of 1.46 billion or 3.59 per share.

Cash & Cash Equivalents	1.51B
Total Debt	50.24M
Net Cash	1.46B
Net Cash Per Share	3.59
Equity (Book Value)	2.56B
Book Value Per Share	5.98
Working Capital	1.56B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 346.74 million and capital expenditures -147.20 million, giving a free cash flow of 199.54 million.

Operating Cash Flow	346.74M
Capital Expenditures	-147.20M
Free Cash Flow	199.54M
FCF Per Share	0.49

Full Cash Flow Statement

Margins

Gross margin is 43.45%, with operating and profit margins of 10.78% and 9.48%.

Gross Margin	43.45%
Operating Margin	10.78%
Pretax Margin	10.77%
Profit Margin	9.48%
EBITDA Margin	17.45%
EBIT Margin	10.78%
FCF Margin	9.30%

Dividends & Yields

This stock pays an annual dividend of 0.05, which amounts to a dividend yield of 0.34%.

Dividend Per Share	0.05
Dividend Yield	0.34%
Dividend Growth (YoY)	1.06%
Years of Dividend Growth	1
Payout Ratio	9.54%
Buyback Yield	-2.40%
Shareholder Yield	-2.06%
Earnings Yield	3.64%
FCF Yield	3.57%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a